Search research articles
Contact Us
Filters
Showing results (481-490 of 501) with videos related to
Page
of 51
Sort By:
The British Journal of Surgery
|
September 6, 2022
Short-term risk prediction after major lower limb amputation: PERCEIVE study
Brenig L Gwilym, Philip Pallmann, Cherry-Ann Waldron, et al.
Psychiatric Services (Washington, D.C.)
|
May 26, 2018
The Influence of Team Functioning and Workload on Sustainability of Trauma-Focused Evidence-Based Psychotherapies
David C Mohr, Craig S Rosen, Paula P Schnurr, et al.
Journal of Anxiety Disorders
|
December 15, 2018
Which patients initiate cognitive processing therapy and prolonged exposure in department of veterans affairs PTSD clinics?
Craig S Rosen, Nancy C Bernardy, Kathleen M Chard, et al.
BJS Open
|
January 24, 2024
Long-term risk prediction after major lower limb amputation: 1-year results of the PERCEIVE study
Brenig Llwyd Gwilym, Philip Pallmann, Cherry-Ann Waldron, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
July 27, 2010
The International EU/COLIPA In Vitro Phototoxicity Validation Study: Results of Phase II (Blind Trial). Part 1: The 3T3 NRU Phototoxicity Test
H Spielmann, M Balls, J Dupuis, et al.
Journal of Personalized Medicine
|
June 2, 2021
Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children's Hospital
Pritmohinder S Gill, Feliciano B Yu, Patricia A Porter-Gill, et al.
Vaccine
|
March 24, 2026
Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in Australia
Lucy Deng, Belinda Barton, Philip Choi, et al.
Biochemical and Biophysical Research Communications
|
October 13, 2007
Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death
Andriani Athanasiou, Anna B Clarke, Amy E Turner, et al.
Human Vaccines & Immunotherapeutics
|
April 26, 2022
Victorian Specialist Immunisation Services (VicSIS) - bolstering adult clinics for COVID-19 vaccines
Sally F Gordon, Elise Virah Sawmy, Eleanor Duckworth, et al.
Vaccine
|
July 5, 2025
Lessons learnt during establishment of COVID-19 active vaccine safety surveillance in nine African countries
Clare L Cutland, Kimberley Gutu, Jessica Ann Yun, et al.
Page
of 51
Search research articles
Search
Showing results (481-490 of 501) with videos related to
Sort By:
Page
of 51
The British Journal of Surgery
|
September 6, 2022
Short-term risk prediction after major lower limb amputation: PERCEIVE study
Brenig L Gwilym, Philip Pallmann, Cherry-Ann Waldron, et al.
Psychiatric Services (Washington, D.C.)
|
May 26, 2018
The Influence of Team Functioning and Workload on Sustainability of Trauma-Focused Evidence-Based Psychotherapies
David C Mohr, Craig S Rosen, Paula P Schnurr, et al.
Journal of Anxiety Disorders
|
December 15, 2018
Which patients initiate cognitive processing therapy and prolonged exposure in department of veterans affairs PTSD clinics?
Craig S Rosen, Nancy C Bernardy, Kathleen M Chard, et al.
BJS Open
|
January 24, 2024
Long-term risk prediction after major lower limb amputation: 1-year results of the PERCEIVE study
Brenig Llwyd Gwilym, Philip Pallmann, Cherry-Ann Waldron, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
July 27, 2010
The International EU/COLIPA In Vitro Phototoxicity Validation Study: Results of Phase II (Blind Trial). Part 1: The 3T3 NRU Phototoxicity Test
H Spielmann, M Balls, J Dupuis, et al.
Journal of Personalized Medicine
|
June 2, 2021
Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children's Hospital
Pritmohinder S Gill, Feliciano B Yu, Patricia A Porter-Gill, et al.
Vaccine
|
March 24, 2026
Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in Australia
Lucy Deng, Belinda Barton, Philip Choi, et al.
Biochemical and Biophysical Research Communications
|
October 13, 2007
Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death
Andriani Athanasiou, Anna B Clarke, Amy E Turner, et al.
Human Vaccines & Immunotherapeutics
|
April 26, 2022
Victorian Specialist Immunisation Services (VicSIS) - bolstering adult clinics for COVID-19 vaccines
Sally F Gordon, Elise Virah Sawmy, Eleanor Duckworth, et al.
Vaccine
|
July 5, 2025
Lessons learnt during establishment of COVID-19 active vaccine safety surveillance in nine African countries
Clare L Cutland, Kimberley Gutu, Jessica Ann Yun, et al.
Page
of 51